Back to the main directory
Company Analysis / Equity
- Slightly Lowering Valuation in Tobacco, but We See Upside to the Group; IMB Our Pick by Morningstar
- Slightly Lowering Valuation in Tobacco, but We See Upside to the Group; IMB Our Pick by Morningstar
- Morningstar | ConvaTec Makes Modest Progress on Turnaround; No Change to Our FVE by Morningstar
- Morningstar | Slightly Lowering Valuation in Tobacco, but We See Upside to the Group; IMB Our Pick by Morningstar
- Morningstar | Slightly Lowering Valuation in Tobacco, but We See Upside to the Group; IMB Our Pick by Morningstar
- Morningstar | Weather Volatility Leads Amerigas to Lower Guidance by Morningstar
- WB: Expect Better 2Q18 Due to Media Events, World Cup and Competitors’ Content Clean Up; Maintain Buy Rating by T.H. Capital
- Exelixis' Cabozantinib Continues to Gain Share; Maintaining $29.50 FVE by Morningstar
- Allstate Reports Strong 2Q, but Long-Term Growth Is Still an Issue by Morningstar
- Morningstar | Exelixis' Cabozantinib Continues to Gain Share; Maintaining $29.50 FVE by Morningstar
- Morningstar | Allstate Reports Strong 2Q, but Long-Term Growth Is Still an Issue by Morningstar
- Energy Transfer Equity's merger offer alleviates cost-of-capital concerns by Morningstar
- Morningstar | Energy Transfer's Consolidation Comes Earlier Than Expected; Upside for ETP. See Updated Analyst Note from 02 Aug 2018 by Morningstar
- Energy Transfer's Consolidation Comes Earlier Than Expected; Upside for ETP by Morningstar
- NiSource Reports Weak 2Q; Investments On Track and No Change to FVE by Morningstar
- Morningstar | Energy Transfer's Consolidation Comes Earlier Than Expected; Upside for ETP by Morningstar
- Morningstar | Competition Sets Stage for Near-Term Softness, but Yum China Still Offers Long-Term Growth Story by Morningstar
- Morningstar | Tight truckload-market capacity a major tailwind for Hub's logistics businesses in 2018. by Morningstar
- MetLife Holds Steady in 2Q, Fully Divests Brighthouse by Morningstar
- Morningstar | Hugo Boss Delivers Sales Improvement but Operating Leverage Doesn't Kick In Yet; FVE Maintained by Morningstar
- Magellan Reports Steady 2Q Due to Refined Products Stability and Improved Crude Earnings by Morningstar
- H218 Looking Good for AME - Overweight by Atlantic Equities
- Morningstar | American Water Reports Strong 2Q; 10% Dividend Growth on Track by Morningstar
- Morningstar | Dexcom Sees Stronger-Than-Expected Sales in 2Q, but Expenses Also Exceeded Our Estimates by Morningstar
- Royal Caribbean Results Handily Surpass Expectations; Shares Undervalued by Morningstar